Glycine is metabolised into a one-carbon unit, activating mTORC1 signalling via glycine transporter-1. Furthermore, glycine ameliorates hepatic inflammation by inhibiting the nuclear factor-kappa B ...

BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ ...

Objective: The hepatic arterial buffer response is a well-known phenomenon in hepatic circulation, describing the response of hepatic arterial resistance to changes in portal vein flow. Several ...

Diagnosis Hepatic vein thrombosis should be suspected when ascites, liver enlargement, and upper abdominal pain are simultaneously present, or when intractable ascites contrasts with mildly ...

The liver has a clear transverse cleft or groove on the visceral surface of both liver lobes which reveal the entrance of the large portal veins, hepatic arteries, the two emerging bile ducts and the ...

THE liver acts as a selective barrier between the gastrointestinal tract and the systemic circulation, metabolizing, detoxifying and elaborating for further physiologic disposition various substanc ...

Transarterial chemoembolization (TACE) is a type of treatment for liver cancer. It works by delivering chemotherapy drugs directly to the tumor and blocking its blood supply.

Background: The failing Fontan circulation is associated with hepatic impairment. The nature of this liver injury is poorly defined. Objective: To establish the gross and histological liver changes of ...

Objective: Cirrhosis is the common end stage of any given chronic liver disease, developing after persistent destruction and regeneration of parenchymal liver cells. The associated architectural ...

Your hepatic veins transport low-oxygen blood from your digestive tract to your heart and ultimately to your lungs. A blockage in your hepatic veins could lead to serious problems with your liver.